Optimized PLGA encapsulated SA-2 nanosuspension exhibits sustained intraocular pressure reduction in the mouse microbead occlusion model of ocular hypertension

Pharmacology, Toxicology and Pharmaceutical Science

• Intraocular Hypertension 100%
• Polyglactin 100%
• Bioavailability 66%
• Open Angle Glaucoma 33%
• Nanoparticle 33%
• Antioxidant 33%
• C57BL 6 Mouse 33%
• Nitric Oxide Donor 33%
• Diseases 33%

Keyphrases

• Microbead Occlusion Model 100%
• Ocular Safety 25%
• Posterior Segment 25%
• Nanoparticle Encapsulation 25%